Verve Therapeutics

221 people · 10 jobs
‌

Verve Therapeutics is a biotechnology company focused on discovering and developing therapies that safely edit the genomes of adults to confer lifelong protection against coronary artery disease, the most common type of heart disease and the leading cause of death worldwide.

Employees

201-500

Links


Org chart

Hiring!

Sekar Kathiresan
Co-Founder & CEO
Collapse
Troy Lister
SVP, Research
Joe Biedenkapp
VP, Editing Development
Caitlin Moreno
Senior Manager, Environmental, Health & Safety
Leslie Stolz
SVP, Regulatory Affairs
Joan Nickerson
SVP, HR & Facilities
Jason Politi
Chief Technical Officer
Mrinal Kumar
Vice President, Strategic Operations
Yasser El-Gamal
VP, Legal Affairs & Chief Intellectual Property Counsel
William F McDonald
Vice President/ Head Of Manufacturing And Supply
Barry Ticho
Co-Founder
J. Keith Joung
Co-Founder

Board & advisors

Burt Adelman
Chairman
Bo Cumbo
Director
Issi Rozen
Strategic Advisor
Anthony Philippakis
Scientific Advisor
Kiran Musunuru
Scientific Advisor
Andrew Geall
Scientific Advisor
Daniel J. Rader
Scientific Advisor
Eugene Braunwald
Scientific Advisor
Penny M. Heaton
Scientific Advisor